Filing Details

Accession Number:
0001104659-13-041517
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-14 17:33:30
Reporting Period:
2013-05-14
Filing Date:
2013-05-14
Accepted Time:
2013-05-14 17:33:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1463729 Receptos Inc. RCPT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1222012 Noubar Afeyan One Memorial Drive, 7Th Floor
Cambridge MA 02142
No No Yes No
1255927 Jr M Edwin Kania One Memorial Drive, 7Th Floor
Cambridge MA 02142
No No Yes No
1508052 Flagship Ventures Fund 2007, L.p. One Memorial Drive, 7Th Floor
Cambridge MA 02142
No No Yes No
1508053 Flagship Ventures 2007 General Partner Llc One Memorial Drive, 7Th Floor
Cambridge MA 02142
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-14 1,152,039 $5.25 1,266,324 No 4 C Direct
Common Stock Acquisiton 2013-05-14 550,873 $7.73 1,817,197 No 4 C Direct
Common Stock Acquisiton 2013-05-14 107,142 $14.00 1,924,339 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2013-05-14 8,640,289 $0.00 1,152,039 $5.25
Common Stock Series B Preferred Stock Disposition 2013-05-14 4,131,552 $0.00 550,873 $7.73
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. The Series A preferred stock and Series B preferred stock converted upon the closing of the Issuer's initial public offering at a conversion ratio of 1 share of common stock for every 7.5 shares of Series A preferred stock and Series B preferred stock, for no additional consideration.
  2. Beneficial ownership consists of: (i) 221,427 shares of common stock held by Flagship Ventures Fund 2007, L.P. ("Flagship Fund"); and (ii) an aggregate of 1,702,912 shares of common stock issued upon conversion of shares of Series A preferred stock and Series B preferred stock held by Flagship Fund. The general partner of Flagship Fund is Flagship Ventures 2007 General Partner LLC ("Flagship GP"), and the managing members of Flagship GP are Noubar B. Afeyan and Edwin M. Kania, Jr. The General Partner and Messrs. Afeyan and Kania have voting and investment control over the shares held by Flagship Fund and may be deemed to be the beneficial owners of such shares and each of them disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein.